학술논문
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele.
Document Type
Article
Author
Goralski, Jennifer L.; Hoppe, Jordana E.; Mall, Marcus A.; McColley, Susanna A.; McKone, Edward; Ramsey, Bonnie; Rayment, Jonathan H.; Robinson, Phil; Stehling, Florian; Taylor-Cousar, Jennifer L.; Tullis, Elizabeth; Ahluwalia, Neil; Anna Chin; Chenghao Chu; Mengdi Lu; Tao Niu; Weinstock, Tanya; Ratjen, Felix; Rosenfeld, Margaret
Source
American Journal of Respiratory & Critical Care Medicine; 7/1/2023, Vol. 208 Issue 1, Following p59-67, 44p
Subject
Language
ISSN
1073449X
Abstract
Copyright of American Journal of Respiratory & Critical Care Medicine is the property of American Thoracic Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)